From: Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers
A: All Biomarkers. | Â | Â | Â | Â | Â |
---|---|---|---|---|---|
 | Estimate | Std. Error | z value | Pr(>|z|) |  |
(Intercept) | 6.39 | 2.52 | 2.54 | 0.01 | Â |
P53 | -0.11 | 0.48 | -0.22 | 0.82 | Â |
C-myc | 0.93 | 0.56 | 1.66 | 0.10 | Â |
IMP1/Koc | -0.21 | 0.56 | -0.37 | 0.71 | Â |
P62/IMP2 | -0.30 | 0.49 | -0.60 | 0.55 | Â |
IMP3 | 0.14 | 0.67 | 0.21 | 0.84 | Â |
Cyclin A | 2.69 | 0.79 | 3.41 | <0.01 | Â |
Cyclin B1 | -0.84 | 0.69 | -1.22 | 0.22 | Â |
Cyclin D1 | -2.70 | 0.83 | -3.27 | <0.01 | Â |
CDK2 | 1.32 | 0.67 | 1.95 | 0.05 | Â |
Survivin | 2.39 | 0.91 | 2.62 | 0.01 | Â |
AIC | 86.60 | Â | Â | Â | Â |
10 fold Cross Validation | 91% | Â | Â | Â | Â |
B: Stepwise Multiple Logistic Model. | Â | Â | Â | Â | Â |
 | Estimate | Odds Ratio | Std. Error | z value | Pr(>|z|) |
(Intercept) | 6.95 | 1043.15 | 2.25 | 3.09 | <0.01 |
C-myc | 0.80 | 2.22 | 0.53 | 1.53 | 0.13 |
Cyclin A | 2.59 | 13.32 | 0.71 | 3.64 | <0.01 |
Cyclin B1 | -0.87 | 0.41 | 0.63 | -1.38 | 0.17 |
Cyclin D1 | -2.73 | 0.06 | 0.69 | -3.94 | <0.01 |
CDK2 | 1.27 | 3.56 | 0.60 | 2.11 | 0.04 |
Survivin | 2.44 | 11.47 | 0.89 | 2.75 | 0.01 |
AIC: | 79.40 | Â | Â | Â | Â |
10 fold Cross Validation | 91% | Â | Â | Â | Â |